Initial investigations into the role of CYLD in malignant melanoma have shown that its transcript or protein level is strongly decreased in primary or metastatic melanomas compared to normal human epidermal melanocytes in vitro as well as in vivo on immunohistochemistry sections [85,87]. The gene discussed is CYLD; the disease is melanoma.